3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
3
Urothelial Carcinoma of the Bladder
1
Squamous Cell Carcinoma of Head and Neck
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroblastoma
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Laryngeal Neoplasms
1
Ganglioneuroblastoma
1
Carcinoma
1
Brain Neoplasms
1
Interventions
Carboplatin
28
pembrolizumab
24
Pemetrexed
24
Specimen Handling
22
Cisplatin
19
Magnetic Resonance Spectroscopy
18
Paclitaxel
14
Gemcitabine
13
Docetaxel
11
Nivolumab
8
osimertinib
7
durvalumab
7
Taxes
7
Immunoglobulin G
7
Disulfides
7
130-nm albumin-bound paclitaxel
7
atezolizumab
6
Platinum
5
Etoposide
5
Cetuximab
5
1,2-diaminocyclohexaneplatinum II citrate
5
X-Rays
4
Ramucirumab
4
Radiotherapy
4
Radiation
4
Observation
4
Interviews as Topic
4
Biopsy
4
Albumin-Bound Paclitaxel
4
Topotecan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Transurethral Resection of Bladder
×
30 days
×
Clear all
No trials found.